Evidence map›Paper›PMID 35432271›Full record

ArticleFrontiers in microbiology2022

Diagnostic Performance of a Novel

Liping Pan, Mailing Huang, Hongyan Jia, Guofang Deng, Yu Chen, Rongrong Wei, Mingxia Zhang, Xin Li, Qi Sun, Mutong Fang and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Transcriptomic insights intoThe veterinary quarterly · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Performance of T-TrackDiagnostics (Basel, Switzerland) · 2023
    Article
  7. Evaluation of theFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Liping PanBeijing Chest Hospital, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Mailing HuangDepartment of Tuberculosis, Beijing Chest Hospital, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Hongyan JiaBeijing Chest Hospital, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Guofang DengDepartment of Pulmonary Medicine, The Third People's Hospital of Shenzhen, Shenzhen, China.
Yu ChenDepartment of Tuberculosis, Henan Provincial Infectious Disease Hospital, Zhengzhou, China.
Rongrong WeiBeijing Chest Hospital, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Mingxia ZhangLaboratory Medical Center, The Third People's Hospital of Shenzhen, Guangdong Key Lab of Emerging Infectious Diseases, Shenzhen, China.
Xin LiLaboratory Medical Center, Henan Provincial Infectious Disease Hospital, Zhengzhou, China.
Qi SunBeijing Chest Hospital, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Mutong FangDepartment of Pulmonary Medicine, The Third People's Hospital of Shenzhen, Shenzhen, China.
Pengfei RenDepartment of Tuberculosis, Henan Provincial Infectious Disease Hospital, Zhengzhou, China.
Aiying XingBeijing Chest Hospital, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Qi ChenLaboratory Medical Center, The Third People's Hospital of Shenzhen, Guangdong Key Lab of Emerging Infectious Diseases, Shenzhen, China.
Xinxin LiDepartment of Tuberculosis, Henan Provincial Infectious Disease Hospital, Zhengzhou, China.
Boping DuBeijing Chest Hospital, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Tao ChenDepartment of Pulmonary Medicine, The Third People's Hospital of Shenzhen, Shenzhen, China.
Mengqiu GaoDepartment of Tuberculosis, Beijing Chest Hospital, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Zongde ZhangBeijing Chest Hospital, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
Beijing Chest Hospital · CNShenzhen Third People’s Hospital · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One-fourth of the world's population has been infected with

Indexed as

CXCL10molecular diagnosismRNAM.tb infectionT-SPOT.TBtuberculosis

Identifiers

PMID35432271
PMCPMC9005954
OpenAlexW4220950298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.